The high P/S ratio at Jiangsu Sihuan Bioengineering, despite...
The high P/S ratio at Jiangsu Sihuan Bioengineering, despite falling revenue and unsatisfactory medium-term growth, is a concern. Unless there's a significant medium-term turnaround, the stock might be overvalued, risking investor disappointment.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more